Government Health Agencies Caution Against Actos Use
The U.S. Food and Drug Administration (FDA) as well as equivalent French and German authorities have taken cautionary measures in an effort to protect their national communities against the potential side effects of Actos (pioglitazone). While each agency’s specific actions have differed, their direction have been the same: to caution consumers and protect patients from potential harm.
What has these health agencies worried? One of Actos’s most disconcerting side effects is the drug’s tendency to significant increase the risk that patients will develop bladder cancer as a result of protracted use.
Are you an Actos user who has experienced harm? You should contact the professionals at Fears Nachawati to learn whether your rights have been violated and what actions you may be able to take as a result. For your free consultation, call us at 1.866.545.8364 or email email@example.com. We’re ready to help you!